NCT00402545 - C-TPF in Patients With Newly Diagnosed Locally Advanced Squamous Cell Carcinoma of the Head and Neck | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

July 31, 2009

Study Completion Date

July 31, 2009

Conditions

Head and Neck Neoplasms

Interventions

DRUG

Cetuximab

Given intravenously on days 1, 8 and 15 of each 21-day cycle for three cycles

DRUG

Docetaxel

Given intravenously on day 1 of each 21-day cycle for 3 cycles

DRUG

Cisplatin

Intravenously on day 1 of each 21-day cycle for 3 cycles

DRUG

5-Fluorouracil

Given by continuous infusion pump over a period of 96 hours(dosage wil vary depending upon when participant enrolls in trial)

Trial Locations (1)

Dana-Farber Cancer Institute, Boston